Researchers Note Cautions About Geron Corporation Drug Imetelstat

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

This morning, an abstract containing new data on Geron GERN +3.76%’s drug imetelstat caused shares in the tiny, Menlo Park, Calif., biotechnology company to more than double to $7.78; they fell some, but still ended the day up 44% to $5.20, giving Geron a market capitalization of $670 million. Obviously, excitement around this medicine is high.

Help employers find you! Check out all the jobs and post your resume.

Back to news